金融界2025年5月9日消息，工银医疗保健股票(000831) 最新净值2.5040元，增长0.72%。该基金近1个月 收益率5.17%，同类排名504|783；近3个月收益率9.06%，同类排名88|778；今年来收益率9.87%，同类 排名103|773。 工银医疗保健股票股票持仓前十占比合计39.79%，分别为：恒瑞医药（8.90%）、药明康德 （5.12%）、艾力斯（4.94%）、百济神州-U（3.77%）、泽璟制药-U（3.52%）、新诺威（3.27%）、 迈瑞医疗（2.80%）、鱼跃医疗（2.76%）、联影医疗（2.47%）、诺诚健华-U（2.24%）。 公开资料显示，工银医疗保健股票基金成立于2014年11月18日，截至2025年3月31日，工银医疗保健股 票规模27.24亿元，基金经理为赵蓓、丁洋。 简历显示：赵蓓女士:硕士,曾在中再资产管理股份有限公司担任投资经理助理。2010年加入工银瑞信,现 任研究部副总监、医疗保健研究团队负责人,2014年11月18日至今,担任工银医疗保健行业股票型基金基 金经理;2015年4月28日至今,担任工银瑞信养老产业股票型基金基金经理;2016年2月3日至今 ...

-40% -20% 0% 20% 40% 60% 80% 100% 北证50 沪深300 ⚫⚫⚫⚫⚫⚫ 资料来源：iFinD，中国银河证券研究院 请务必阅读正文最后的中国银河证券股份有限公司免责声明。 2 10 图1:北证成交额与换手率情况(截至2025.05.08) ■成交金额（合计/亿元) ●换手率（算数平均/%） 600 16.0 14.0 500 12.0 400 10.0 300 8.0 6.0 200 4.0 100 2.0 0 0.0 03-11 03-14 04-15 02-10 8T 70 ET 70 02-26 03-03 03-06 03-19 03-24 03-27 04-07 04-10 04-18 04-23 04-28 05-06 01-02 01-15 02-05 02-21 04-01 01-23 01- 01 可证券|CGS 中国银河证券|CGS 北交所日报 资料来源：iFinD，中国银河证券研究院 图2：北证与 A 股各行业当日涨跌幅（算数平均/%/ 2025.05.08) ■北交所算数平均涨跌幅 ■Ａ股算数平均涨跌幅 12 10 8 6 4 2 0 -2 -4 北交所日 ...

机构调研榜单中，共有239家公司获20家以上机构扎堆调研。兆威机电最受关注，参与调研的机构达到 332家；联影医疗被285家机构调研，榜单中排名第二；华勤技术、韦尔股份等分别被278家、259家机构 调研。 机构调研次数来看，曼卡龙机构调研最为密集，共获机构5次调研。伟星股份、天康生物等机构调研也 较为密集，分别被机构调研3次、2次。 近5日机构合计调研427家公司，兆威机电、联影医疗、华勤技术等被多家机构扎堆调研。 证券时报·数据宝统计，近5个交易日（4月29日至5月8日）两市约427家公司被机构调研，调研机构类型 显示，证券公司共对396家公司进行调研，即92.74%的上市公司调研活动有证券公司参与；基金公司调 研353家，位列其后；阳光私募机构调研260家，排名第三。 | 300979 | 华利集团 | 2 | 39 | 53.78 | -4.80 | 纺织服饰 | | --- | --- | --- | --- | --- | --- | --- | | 688512 | 慧智微 | 1 | 39 | 10.60 | 6.85 | 电子 | | 688356 | 键凯科技 | 1 | 38 | 61. ...

5月8日沪指上涨0.28%，市场两融余额为18087.55亿元，较前一交易日增加918.65万元。 证券时报·数据宝统计显示，截至5月8日，沪市两融余额9191.44亿元，较前一交易日增加0.80亿元；深 市两融余额8843.61亿元，较前一交易日减少1.32亿元；北交所两融余额52.50亿元，较前一交易日增加 0.60亿元；深沪北两融余额合计18087.55亿元，较前一交易日增加918.65万元。 分行业看，申万所属行业中，融资余额增加的行业有15个，增加金额最多的行业是电子，融资余额增加 6.03亿元；其次是机械设备、通信行业，融资余额分别增加5.51亿元、4.40亿元。 具体到个股来看，融资余额出现增长的股票有1854只，占比50.52%，其中，304股融资余额增幅超过 5%。融资余额增幅最大的是美心翼申，该股最新融资余额1820.60万元，较前一交易日增幅达 138.22%；股价表现上，该股当日上涨9.01%，表现强于沪指；融资余额增幅较多的还有锦好医疗、瑞 星股份，融资余额增幅分别为120.43%、88.42%。 融资余额增幅前20只个股中，从市场表现来看，平均上涨2.47%，涨幅居前的有航天南湖、 ...

Group 1 - The China Securities Regulatory Commission (CSRC) issued the "Action Plan for Promoting the High-Quality Development of Public Funds," which includes 25 measures aimed at optimizing the fee structure for actively managed equity funds and enhancing the alignment of interests between fund companies and investors [1][2] - The plan emphasizes the need for over 20 supporting regulations to be developed for implementation, with a timeline for each policy measure already established by the CSRC [1] Group 2 - Fund managers of products with performance below the benchmark by more than 10 percentage points over three years will face significant reductions in their performance-based compensation, as highlighted in the new measures [2] - A notable number of funds have underperformed their benchmarks, with some lagging by over 50 percentage points [2] Group 3 - The Fuanda CSI A500 Index Enhanced Fund experienced a significant redemption event shortly after its launch, prompting the fund to adjust its net asset value precision [3] - The fund was established with a size of 425 million yuan and has seen a slight loss since inception, with its net asset value currently below 1 yuan [3] Group 4 - In April, public fund institutions conducted a record 9,796 research visits to A-share listed companies, marking a 129.47% increase from March [4] - The electronics sector was the most favored, receiving 1,754 visits, followed by the pharmaceutical and biological sector with 1,400 visits [4] Group 5 - Two ETFs, the Huazhang International Leader (DAX) and the Invesco S&P Consumer Select ETF, have issued warnings about significant premium risks in their secondary market trading prices, which are notably higher than their net asset values [5] - The Invesco S&P Consumer Select ETF has issued premium risk warnings for nine consecutive trading days [5] Group 6 - Liu Gesong's fund, Guangfa Small Cap Growth Mixed Fund, increased its holdings in Kesi Technology, raising its share count from 797,400 to 1,045,100, indicating a 24.77% increase in shares held [6] - Kesi Technology has been included in the top holdings of the Guangfa Small Cap Growth Mixed Fund [6] Group 7 - On May 8, the market saw a rise in major indices, with the Shanghai Composite Index up by 0.28% and the Shenzhen Component Index up by 0.93%, while the ChiNext Index rose by 1.65% [7] - The total trading volume in the Shanghai and Shenzhen markets was 1.29 trillion yuan, a decrease of 174.9 billion yuan from the previous trading day [7]

Group 1 - The core conclusion indicates that active equity funds have increased their positions, with a preference for Hong Kong stocks and the Sci-Tech Innovation Board [1][18] - In Q1 2025, the market value of active equity funds decreased slightly to 2.50 trillion yuan, with a net redemption of approximately 482 billion yuan, indicating manageable pressure on the market [10][15] - The allocation to Hong Kong stocks has risen for five consecutive quarters, while the main board and ChiNext have seen significant declines in allocation [18][21] Group 2 - Active equity funds have shown a trend of profit-taking in growth and consumer sectors, with notable reductions in positions in electronics, pharmaceuticals, and food and beverage sectors [2][38] - The only sector to see an increase in active equity fund positions in Q1 2025 was the automotive sector, while the electric power equipment sector experienced significant reductions [40][45] - The top five industries by allocation in active equity funds include electronics (18.4%), electric power equipment (11.0%), pharmaceuticals (10.6%), food and beverage (8.8%), and automotive (7.8%) [22][23] Group 3 - The pricing power of active equity funds is highest in the automotive (2.9%) and electronics (3.5%) sectors, with a notable increase in automotive pricing power [3][49] - The overall pricing power of active equity funds has slightly decreased, with the exception of the CSI 500 and CSI 1000 indices, which have shown an upward trend [47][49] - The top five industries by pricing power are home appliances (3.8%), electronics (3.5%), electric power equipment (3.0%), automotive (2.9%), and pharmaceuticals (2.7%) [49]

Market Performance - The average daily change for the North Exchange (北证) and A-shares (A股) shows significant fluctuations, with the North Exchange experiencing a maximum increase of 29.99% for the top-performing stock on May 8, 2025[9] - The trading volume for the North Exchange reached a total of 600 billion CNY, with an average turnover rate of 16% as of May 8, 2025[7] Stock Highlights - The top ten stocks by increase on May 8, 2025, had an average market capitalization of 19.06 billion CNY, with the highest PE ratio recorded at 570.74 for Tongyi Aerospace (通易航天) despite a negative net profit[9] - Conversely, the bottom ten stocks by decrease had an average market capitalization of 32.48 billion CNY, with the largest drop of -7.57% for Qiule Seed Industry (秋乐种业)[10] Valuation Insights - The PE ratio for the North Exchange companies varies significantly across industries, indicating diverse valuation levels, with some sectors like electronics showing extremely high PE ratios, such as 2,690.19 for Huiwei Intelligent (慧为智能)[11] - The valuation trends for the North Exchange compared to the Sci-Tech Board and Growth Enterprise Market indicate a competitive landscape, with the North Exchange showing a steady increase in valuation metrics[12] Risks and Considerations - Potential risks include lower-than-expected policy support, insufficient technological innovation, intensified market competition, and overall market volatility[14]

市场表现方面，机构买入型评级个股今日平均上涨0.63%，表现强于沪指。股价上涨的有98只，涨停的 有神驰机电等。涨幅居前的有三友医疗、新大陆、苏轴股份等，今日涨幅分别为9.15%、7.09%、 5.93%。跌幅较大的个股有潮宏基、菜百股份、稳健医疗等，跌幅分别为4.75%、4.36%、3.41%。 行业来看，电子、医药生物等行业最受青睐，均有23只个股上榜机构买入评级榜。电力设备、机械设备 等行业也较受机构关注，分别有14只、12只个股上榜。（数据宝） 机构今日买入型评级个股 | 代码 | 简称 | 买入评级家数 | 今日涨跌幅（%） | 动态市盈率（倍） | 行业 | | --- | --- | --- | --- | --- | --- | | 605117 | 德业股份 | 3 | 1.26 | 20.41 | 电力设备 | | 688580 | 伟思医疗 | 2 | 0.10 | | 医药生物 | | 688029 | 南微医学 | 2 | 1.26 | | 医药生物 | | 688351 | 微电生理 | 2 | -0.18 | | 医药生物 | | 600642 | 申能股份 | 2 | 0.11 ...

华福证券 2025 年 05 月 08 日 策 略 研 究 医疗与消费周报——信玖凝获批：我国基因治疗 药物行业发展推进中 投资要点： 近期观点 1、医药指数本周（4.28-4.30）关注的 6 个子行业三分之二录得正 收益，表现良好。 策 略 定 期 报 告 2、2025 年 4 月 11 日，中国首个血友病 B 基因治疗药物信玖凝（波 哌达可基注射液）获批上市，从研发到上市仅用不到七年。基因疗法 是通过导入外源基因置换或纠正致病基因，实现"一次治疗，长期有 效"。医麦克《基因治疗药物行业发展白皮书》显示，2025 年中国基 因疗法市场规模预计达 25.9 亿美元，2025-2027 年有望达 500 亿元。 中国罕见病约 2000 种，基因疗法潜力巨大。中国丰富的基因组学数据 为研究提供支持，但基因疗法仍面临技术安全性、伦理、法规及成本 等挑战，新的基因编辑工具和递送系统为其发展提供动力。 团队成员 分析师： 赵月(S0210524050016) zy30563@hfzq.com.cn 相关报告 风险提示 技术研发不及预期；宏观需求变化；地缘政治影响 证 券 研 究 报 告 诚信专业 发现价值 1 请务必 ...

173只创业板股公布截至4月30日最新股东户数，环比上期，股东户数下降的有79只，降幅超过一成的有 4只。 证券时报·数据宝统计显示，173只创业板股公布了4月30日股东户数，与上期（4月20日）比，股东户数 下降的有79只，其中股东户数降幅超一成的有4只。股东户数环比增长的有79只。 股东户数降幅最多的是蕾奥规划，截至4月30日最新股东户数为9814户，较4月20日下降18.51%，筹码 集中以来该股累计下跌10.74%，累计换手率为75.44%，其间主力资金净流出5269.18万元。 其次是山水比德，截至4月30日最新股东户数为5359户，较4月20日下降14.39%，筹码集中以来该股累 计上涨34.90%，累计换手率为45.92%。 *ST清研最新股东户数5932户，环比下降14.14%，筹码集中以来股价下跌0.27%，累计换手率为 64.10%。 市场表现方面，最新一期筹码集中股4月21日以来平均上涨6.37%，涨幅居前的有常山药业、山水比 德、金凯生科等，分别上涨41.48%、34.90%、31.90%。所属行业来看，筹码集中股中机械设备、电 子、环保等行业最为集中，分别有14只、11只、7只个股上 ...